{"pmid":32365353,"title":"Rapid reconstruction of SARS-CoV-2 using a synthetic genomics platform.","text":["Rapid reconstruction of SARS-CoV-2 using a synthetic genomics platform.","Reverse genetics has been an indispensable tool revolutionising insights into viral pathogenesis and vaccine development. Large RNA virus genomes, such as from Coronaviruses, are cumbersome to clone and manipulate in E. coli due to size and occasional instability(1-3). Therefore, an alternative rapid and robust reverse genetics platform for RNA viruses would benefit the research community. Here we show the full functionality of a yeast-based synthetic genomics platform to genetically reconstruct diverse RNA viruses, including members of the Coronaviridae, Flaviviridae and Paramyxoviridae families. Viral subgenomic fragments were generated using viral isolates, cloned viral DNA, clinical samples, or synthetic DNA, and reassembled in one step in Saccharomyces cerevisiae using transformation associated recombination (TAR) cloning to maintain the genome as a yeast artificial chromosome (YAC). T7-RNA polymerase has been used to generate infectious RNA to rescue viable virus. Based on this platform we have been able to engineer and resurrect chemically-synthetized clones of the recent epidemic SARS-CoV-2(4) in only a week after receipt of the synthetic DNA fragments. The technical advance we describe here allows a rapidly response to emerging viruses as it enables the generation and functional characterization of evolving RNA virus variants-in real-time-during an outbreak.","Nature","Thao, Tran Thi Nhu","Labroussaa, Fabien","Ebert, Nadine","V'kovski, Philip","Stalder, Hanspeter","Portmann, Jasmine","Kelly, Jenna","Steiner, Silvio","Holwerda, Melle","Kratzel, Annika","Gultom, Mitra","Schmied, Kimberly","Laloli, Laura","Husser, Linda","Wider, Manon","Pfaender, Stephanie","Hirt, Dagny","Cippa, Valentina","Crespo-Pomar, Silvia","Schroder, Simon","Muth, Doreen","Niemeyer, Daniela","Corman, Victor","Muller, Marcel A","Drosten, Christian","Dijkman, Ronald","Jores, Joerg","Thiel, Volker","32365353"],"abstract":["Reverse genetics has been an indispensable tool revolutionising insights into viral pathogenesis and vaccine development. Large RNA virus genomes, such as from Coronaviruses, are cumbersome to clone and manipulate in E. coli due to size and occasional instability(1-3). Therefore, an alternative rapid and robust reverse genetics platform for RNA viruses would benefit the research community. Here we show the full functionality of a yeast-based synthetic genomics platform to genetically reconstruct diverse RNA viruses, including members of the Coronaviridae, Flaviviridae and Paramyxoviridae families. Viral subgenomic fragments were generated using viral isolates, cloned viral DNA, clinical samples, or synthetic DNA, and reassembled in one step in Saccharomyces cerevisiae using transformation associated recombination (TAR) cloning to maintain the genome as a yeast artificial chromosome (YAC). T7-RNA polymerase has been used to generate infectious RNA to rescue viable virus. Based on this platform we have been able to engineer and resurrect chemically-synthetized clones of the recent epidemic SARS-CoV-2(4) in only a week after receipt of the synthetic DNA fragments. The technical advance we describe here allows a rapidly response to emerging viruses as it enables the generation and functional characterization of evolving RNA virus variants-in real-time-during an outbreak."],"journal":"Nature","authors":["Thao, Tran Thi Nhu","Labroussaa, Fabien","Ebert, Nadine","V'kovski, Philip","Stalder, Hanspeter","Portmann, Jasmine","Kelly, Jenna","Steiner, Silvio","Holwerda, Melle","Kratzel, Annika","Gultom, Mitra","Schmied, Kimberly","Laloli, Laura","Husser, Linda","Wider, Manon","Pfaender, Stephanie","Hirt, Dagny","Cippa, Valentina","Crespo-Pomar, Silvia","Schroder, Simon","Muth, Doreen","Niemeyer, Daniela","Corman, Victor","Muller, Marcel A","Drosten, Christian","Dijkman, Ronald","Jores, Joerg","Thiel, Volker"],"date":"2020-05-05T11:00:00Z","year":2020,"_id":"32365353","source":"PubMed","week":"202019|May 04 - May 10","doi":"10.1038/s41586-020-2294-9","locations":["Coronaviruses","Flaviviridae"],"topics":["Mechanism"],"weight":1,"_version_":1666138496105971712,"score":9.490897,"similar":[{"pmid":32289263,"pmcid":"PMC7153529","title":"An Infectious cDNA Clone of SARS-CoV-2.","text":["An Infectious cDNA Clone of SARS-CoV-2.","The ongoing pandemic of COVID-19, caused by severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2), underscores the urgency to develop experimental systems for studying this virus and identifying countermeasures. We report a reverse genetic system for SARS-CoV-2. Seven complimentary DNA (cDNA) fragments spanning the SARS-CoV-2 genome were assembled into a full-genome cDNA. RNA transcribed from the full-genome cDNA was highly infectious after electroporation into cells, producing 2.9 x 10(6) plaque-forming unit (PFU)/mL of virus. Compared with a clinical isolate, the infectious-clone-derived SARS-CoV-2 (icSARS-CoV-2) exhibited similar plaque morphology, viral RNA profile, and replication kinetics. Additionally, icSARS-CoV-2 retained engineered molecular markers and did not acquire other mutations. We generated a stable mNeonGreen SARS-CoV-2 (icSARS-CoV-2-mNG) by introducing this reporter gene into ORF7 of the viral genome. icSARS-CoV-2-mNG was successfully used to evaluate the antiviral activities of interferon (IFN). Collectively, the reverse genetic system and reporter virus provide key reagents to study SARS-CoV-2 and develop countermeasures.","Cell Host Microbe","Xie, Xuping","Muruato, Antonio","Lokugamage, Kumari G","Narayanan, Krishna","Zhang, Xianwen","Zou, Jing","Liu, Jianying","Schindewolf, Craig","Bopp, Nathen E","Aguilar, Patricia V","Plante, Kenneth S","Weaver, Scott C","Makino, Shinji","LeDuc, James W","Menachery, Vineet D","Shi, Pei-Yong","32289263"],"abstract":["The ongoing pandemic of COVID-19, caused by severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2), underscores the urgency to develop experimental systems for studying this virus and identifying countermeasures. We report a reverse genetic system for SARS-CoV-2. Seven complimentary DNA (cDNA) fragments spanning the SARS-CoV-2 genome were assembled into a full-genome cDNA. RNA transcribed from the full-genome cDNA was highly infectious after electroporation into cells, producing 2.9 x 10(6) plaque-forming unit (PFU)/mL of virus. Compared with a clinical isolate, the infectious-clone-derived SARS-CoV-2 (icSARS-CoV-2) exhibited similar plaque morphology, viral RNA profile, and replication kinetics. Additionally, icSARS-CoV-2 retained engineered molecular markers and did not acquire other mutations. We generated a stable mNeonGreen SARS-CoV-2 (icSARS-CoV-2-mNG) by introducing this reporter gene into ORF7 of the viral genome. icSARS-CoV-2-mNG was successfully used to evaluate the antiviral activities of interferon (IFN). Collectively, the reverse genetic system and reporter virus provide key reagents to study SARS-CoV-2 and develop countermeasures."],"journal":"Cell Host Microbe","authors":["Xie, Xuping","Muruato, Antonio","Lokugamage, Kumari G","Narayanan, Krishna","Zhang, Xianwen","Zou, Jing","Liu, Jianying","Schindewolf, Craig","Bopp, Nathen E","Aguilar, Patricia V","Plante, Kenneth S","Weaver, Scott C","Makino, Shinji","LeDuc, James W","Menachery, Vineet D","Shi, Pei-Yong"],"date":"2020-04-15T11:00:00Z","year":2020,"_id":"32289263","source":"PubMed","week":"202016|Apr 13 - Apr 19","doi":"10.1016/j.chom.2020.04.004","keywords":["covid-19","sars-cov","sars-cov-2","antiviral","coronavirus","vaccine"],"topics":["Mechanism"],"weight":1,"_version_":1666138491338096641,"score":419.6101},{"pmid":32296735,"pmcid":"PMC7156160","title":"Prudently conduct the engineering and synthesis of the SARS-CoV-2 virus.","text":["Prudently conduct the engineering and synthesis of the SARS-CoV-2 virus.","Regarding to the recent work of engineering SARS-CoV-19 virus and the publication \"Rapid reconstruction of SARS-CoV-2 using a synthetic genomics platform\" by researchers at University of Bern, this paper comments on the \"dual-use\" problem and regulation issue of synthetic biology from the perspective of responsible (research and) innovation, biosafety and biosecurity. Based on the ethical and legal framework, the authors suggest to conduct such research with high potential risks prudently and responsibly.","Synth Syst Biotechnol","Ma, Shiwen","Gao, Peng","Lu, Daru","Wang, Guoyu","32296735"],"abstract":["Regarding to the recent work of engineering SARS-CoV-19 virus and the publication \"Rapid reconstruction of SARS-CoV-2 using a synthetic genomics platform\" by researchers at University of Bern, this paper comments on the \"dual-use\" problem and regulation issue of synthetic biology from the perspective of responsible (research and) innovation, biosafety and biosecurity. Based on the ethical and legal framework, the authors suggest to conduct such research with high potential risks prudently and responsibly."],"journal":"Synth Syst Biotechnol","authors":["Ma, Shiwen","Gao, Peng","Lu, Daru","Wang, Guoyu"],"date":"2020-04-17T11:00:00Z","year":2020,"_id":"32296735","source":"PubMed","week":"202016|Apr 13 - Apr 19","doi":"10.1016/j.synbio.2020.03.002","keywords":["dual-use","engineering sars-cov-2 virus","regulation","responsible (research and) innovation","risk"],"weight":0,"_version_":1666138493322002432,"score":250.14957},{"pmid":32446559,"title":"Stability of RNA sequences derived from the coronavirus genome in human cells.","text":["Stability of RNA sequences derived from the coronavirus genome in human cells.","Most viruses inhibit the innate immune system and/or the RNA degradation processes of host cells to construct an advantageous intracellular environment for their survival. Characteristic RNA sequences within RNA virus genomes or RNAs transcribed from DNA virus genomes contribute toward this inhibition. In this study, we developed a method called \"Fate-seq\" to comprehensively identify the RNA sequences derived from RNA and DNA viruses, contributing RNA stability in the cells. We examined the stabilization activity of 5,924 RNA fragments derived from 26 different viruses (16 RNA viruses and 10 DNA viruses) using next-generation sequencing of these RNAs fused 3' downstream of GFP reporter RNA. With the Fate-seq approach, we detected multiple virus-derived RNA sequences that stabilized GFP reporter RNA, including sequences derived from severe acute respiratory syndrome-related coronavirus (SARS-CoV). Comparative genomic analysis revealed that these RNA sequences and their predicted secondary structures are highly conserved between SARS-CoV and the novel coronavirus, SARS-CoV-2, which is responsible for the global outbreak of the coronavirus-associated disease that emerged in December 2019 (COVID-19). These sequences have the potential to enhance the stability of viral RNA genomes, thereby augmenting viral replication efficiency and virulence.","Biochem Biophys Res Commun","Wakida, Hiroyasu","Kawata, Kentaro","Yamaji, Yuta","Hattori, Emi","Tsuchiya, Takaho","Wada, Youichiro","Ozaki, Haruka","Akimitsu, Nobuyoshi","32446559"],"abstract":["Most viruses inhibit the innate immune system and/or the RNA degradation processes of host cells to construct an advantageous intracellular environment for their survival. Characteristic RNA sequences within RNA virus genomes or RNAs transcribed from DNA virus genomes contribute toward this inhibition. In this study, we developed a method called \"Fate-seq\" to comprehensively identify the RNA sequences derived from RNA and DNA viruses, contributing RNA stability in the cells. We examined the stabilization activity of 5,924 RNA fragments derived from 26 different viruses (16 RNA viruses and 10 DNA viruses) using next-generation sequencing of these RNAs fused 3' downstream of GFP reporter RNA. With the Fate-seq approach, we detected multiple virus-derived RNA sequences that stabilized GFP reporter RNA, including sequences derived from severe acute respiratory syndrome-related coronavirus (SARS-CoV). Comparative genomic analysis revealed that these RNA sequences and their predicted secondary structures are highly conserved between SARS-CoV and the novel coronavirus, SARS-CoV-2, which is responsible for the global outbreak of the coronavirus-associated disease that emerged in December 2019 (COVID-19). These sequences have the potential to enhance the stability of viral RNA genomes, thereby augmenting viral replication efficiency and virulence."],"journal":"Biochem Biophys Res Commun","authors":["Wakida, Hiroyasu","Kawata, Kentaro","Yamaji, Yuta","Hattori, Emi","Tsuchiya, Takaho","Wada, Youichiro","Ozaki, Haruka","Akimitsu, Nobuyoshi"],"date":"2020-05-25T11:00:00Z","year":2020,"_id":"32446559","source":"PubMed","week":"202022|May 25 - May 31","doi":"10.1016/j.bbrc.2020.05.008","keywords":["covid-19","functional sequence","rna stability","sars-cov","sars-cov-2","virus"],"topics":["Mechanism"],"weight":1,"_version_":1667698385971314688,"score":237.45798},{"pmid":32433465,"title":"Immunogenicity of a DNA vaccine candidate for COVID-19.","text":["Immunogenicity of a DNA vaccine candidate for COVID-19.","The coronavirus family member, SARS-CoV-2 has been identified as the causal agent for the pandemic viral pneumonia disease, COVID-19. At this time, no vaccine is available to control further dissemination of the disease. We have previously engineered a synthetic DNA vaccine targeting the MERS coronavirus Spike (S) protein, the major surface antigen of coronaviruses, which is currently in clinical study. Here we build on this prior experience to generate a synthetic DNA-based vaccine candidate targeting SARS-CoV-2 S protein. The engineered construct, INO-4800, results in robust expression of the S protein in vitro. Following immunization of mice and guinea pigs with INO-4800 we measure antigen-specific T cell responses, functional antibodies which neutralize the SARS-CoV-2 infection and block Spike protein binding to the ACE2 receptor, and biodistribution of SARS-CoV-2 targeting antibodies to the lungs. This preliminary dataset identifies INO-4800 as a potential COVID-19 vaccine candidate, supporting further translational study.","Nat Commun","Smith, Trevor R F","Patel, Ami","Ramos, Stephanie","Elwood, Dustin","Zhu, Xizhou","Yan, Jian","Gary, Ebony N","Walker, Susanne N","Schultheis, Katherine","Purwar, Mansi","Xu, Ziyang","Walters, Jewell","Bhojnagarwala, Pratik","Yang, Maria","Chokkalingam, Neethu","Pezzoli, Patrick","Parzych, Elizabeth","Reuschel, Emma L","Doan, Arthur","Tursi, Nicholas","Vasquez, Miguel","Choi, Jihae","Tello-Ruiz, Edgar","Maricic, Igor","Bah, Mamadou A","Wu, Yuanhan","Amante, Dinah","Park, Daniel H","Dia, Yaya","Ali, Ali Raza","Zaidi, Faraz I","Generotti, Alison","Kim, Kevin Y","Herring, Timothy A","Reeder, Sophia","Andrade, Viviane M","Buttigieg, Karen","Zhao, Gan","Wu, Jiun-Ming","Li, Dan","Bao, Linlin","Liu, Jiangning","Deng, Wei","Qin, Chuan","Brown, Ami Shah","Khoshnejad, Makan","Wang, Nianshuang","Chu, Jacqueline","Wrapp, Daniel","McLellan, Jason S","Muthumani, Kar","Wang, Bin","Carroll, Miles W","Kim, J Joseph","Boyer, Jean","Kulp, Daniel W","Humeau, Laurent M P F","Weiner, David B","Broderick, Kate E","32433465"],"abstract":["The coronavirus family member, SARS-CoV-2 has been identified as the causal agent for the pandemic viral pneumonia disease, COVID-19. At this time, no vaccine is available to control further dissemination of the disease. We have previously engineered a synthetic DNA vaccine targeting the MERS coronavirus Spike (S) protein, the major surface antigen of coronaviruses, which is currently in clinical study. Here we build on this prior experience to generate a synthetic DNA-based vaccine candidate targeting SARS-CoV-2 S protein. The engineered construct, INO-4800, results in robust expression of the S protein in vitro. Following immunization of mice and guinea pigs with INO-4800 we measure antigen-specific T cell responses, functional antibodies which neutralize the SARS-CoV-2 infection and block Spike protein binding to the ACE2 receptor, and biodistribution of SARS-CoV-2 targeting antibodies to the lungs. This preliminary dataset identifies INO-4800 as a potential COVID-19 vaccine candidate, supporting further translational study."],"journal":"Nat Commun","authors":["Smith, Trevor R F","Patel, Ami","Ramos, Stephanie","Elwood, Dustin","Zhu, Xizhou","Yan, Jian","Gary, Ebony N","Walker, Susanne N","Schultheis, Katherine","Purwar, Mansi","Xu, Ziyang","Walters, Jewell","Bhojnagarwala, Pratik","Yang, Maria","Chokkalingam, Neethu","Pezzoli, Patrick","Parzych, Elizabeth","Reuschel, Emma L","Doan, Arthur","Tursi, Nicholas","Vasquez, Miguel","Choi, Jihae","Tello-Ruiz, Edgar","Maricic, Igor","Bah, Mamadou A","Wu, Yuanhan","Amante, Dinah","Park, Daniel H","Dia, Yaya","Ali, Ali Raza","Zaidi, Faraz I","Generotti, Alison","Kim, Kevin Y","Herring, Timothy A","Reeder, Sophia","Andrade, Viviane M","Buttigieg, Karen","Zhao, Gan","Wu, Jiun-Ming","Li, Dan","Bao, Linlin","Liu, Jiangning","Deng, Wei","Qin, Chuan","Brown, Ami Shah","Khoshnejad, Makan","Wang, Nianshuang","Chu, Jacqueline","Wrapp, Daniel","McLellan, Jason S","Muthumani, Kar","Wang, Bin","Carroll, Miles W","Kim, J Joseph","Boyer, Jean","Kulp, Daniel W","Humeau, Laurent M P F","Weiner, David B","Broderick, Kate E"],"date":"2020-05-21T11:00:00Z","year":2020,"_id":"32433465","source":"PubMed","week":"202021|May 18 - May 24","doi":"10.1038/s41467-020-16505-0","topics":["Treatment","Mechanism"],"weight":1,"_version_":1667342288138797057,"score":233.53372},{"pmid":32330414,"pmcid":"PMC7179501","title":"The Architecture of SARS-CoV-2 Transcriptome.","text":["The Architecture of SARS-CoV-2 Transcriptome.","SARS-CoV-2 is a betacoronavirus responsible for the COVID-19 pandemic. Although the SARS-CoV-2 genome was reported recently, its transcriptomic architecture is unknown. Utilizing two complementary sequencing techniques, we present a high-resolution map of the SARS-CoV-2 transcriptome and epitranscriptome. DNA nanoball sequencing shows that the transcriptome is highly complex owing to numerous discontinuous transcription events. In addition to the canonical genomic and 9 subgenomic RNAs, SARS-CoV-2 produces transcripts encoding unknown ORFs with fusion, deletion, and/or frameshift. Using nanopore direct RNA sequencing, we further find at least 41 RNA modification sites on viral transcripts, with the most frequent motif, AAGAA. Modified RNAs have shorter poly(A) tails than unmodified RNAs, suggesting a link between the modification and the 3' tail. Functional investigation of the unknown transcripts and RNA modifications discovered in this study will open new directions to our understanding of the life cycle and pathogenicity of SARS-CoV-2.","Cell","Kim, Dongwan","Lee, Joo-Yeon","Yang, Jeong-Sun","Kim, Jun Won","Kim, V Narry","Chang, Hyeshik","32330414"],"abstract":["SARS-CoV-2 is a betacoronavirus responsible for the COVID-19 pandemic. Although the SARS-CoV-2 genome was reported recently, its transcriptomic architecture is unknown. Utilizing two complementary sequencing techniques, we present a high-resolution map of the SARS-CoV-2 transcriptome and epitranscriptome. DNA nanoball sequencing shows that the transcriptome is highly complex owing to numerous discontinuous transcription events. In addition to the canonical genomic and 9 subgenomic RNAs, SARS-CoV-2 produces transcripts encoding unknown ORFs with fusion, deletion, and/or frameshift. Using nanopore direct RNA sequencing, we further find at least 41 RNA modification sites on viral transcripts, with the most frequent motif, AAGAA. Modified RNAs have shorter poly(A) tails than unmodified RNAs, suggesting a link between the modification and the 3' tail. Functional investigation of the unknown transcripts and RNA modifications discovered in this study will open new directions to our understanding of the life cycle and pathogenicity of SARS-CoV-2."],"journal":"Cell","authors":["Kim, Dongwan","Lee, Joo-Yeon","Yang, Jeong-Sun","Kim, Jun Won","Kim, V Narry","Chang, Hyeshik"],"date":"2020-04-25T11:00:00Z","year":2020,"_id":"32330414","source":"PubMed","week":"202017|Apr 20 - Apr 26","doi":"10.1016/j.cell.2020.04.011","keywords":["covid-19","rna modification","sars-cov-2","coronavirus","direct rna sequencing","discontinuous transcription","epitranscriptome","nanopore","poly(a) tail","transcriptome"],"topics":["Mechanism"],"weight":1,"_version_":1666138494658936834,"score":198.34204}]}